ZA988638B - Use of combinations comprising non-sedating antihistamines and alpha-adrenergic drugs for the topical treatment or rhinitis/conjunctivitis and cold cold-like and/or flu symptoms - Google Patents

Use of combinations comprising non-sedating antihistamines and alpha-adrenergic drugs for the topical treatment or rhinitis/conjunctivitis and cold cold-like and/or flu symptoms

Info

Publication number
ZA988638B
ZA988638B ZA988638A ZA988638A ZA988638B ZA 988638 B ZA988638 B ZA 988638B ZA 988638 A ZA988638 A ZA 988638A ZA 988638 A ZA988638 A ZA 988638A ZA 988638 B ZA988638 B ZA 988638B
Authority
ZA
South Africa
Prior art keywords
cold
conjunctivitis
rhinitis
alpha
combinations
Prior art date
Application number
ZA988638A
Other languages
English (en)
Inventor
Maria Del Carmen Diez Crespo
Roberto Mainardi
Stefan Szelenyi
Reinhard Muckenschnabel
Original Assignee
Asta Medica Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asta Medica Ag filed Critical Asta Medica Ag
Publication of ZA988638B publication Critical patent/ZA988638B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
ZA988638A 1997-09-22 1998-09-21 Use of combinations comprising non-sedating antihistamines and alpha-adrenergic drugs for the topical treatment or rhinitis/conjunctivitis and cold cold-like and/or flu symptoms ZA988638B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP97116494A EP0903151A1 (fr) 1997-09-22 1997-09-22 Utilisation de combinations comprenant des antihistamines non sédatives et des agonistes alpha-adrenergiques pour le traitement topical du rhinitis/conjunctivitis et des symptomes du rhume et de la grippe

Publications (1)

Publication Number Publication Date
ZA988638B true ZA988638B (en) 1999-03-23

Family

ID=8227389

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA988638A ZA988638B (en) 1997-09-22 1998-09-21 Use of combinations comprising non-sedating antihistamines and alpha-adrenergic drugs for the topical treatment or rhinitis/conjunctivitis and cold cold-like and/or flu symptoms

Country Status (12)

Country Link
US (1) US20020037297A1 (fr)
EP (1) EP0903151A1 (fr)
JP (1) JP2001517639A (fr)
AU (1) AU9540098A (fr)
BR (1) BR9812361A (fr)
CA (1) CA2304162A1 (fr)
DE (1) DE19882573T1 (fr)
ES (1) ES2171356B2 (fr)
NO (1) NO20001459L (fr)
PL (1) PL339541A1 (fr)
WO (1) WO1999015203A1 (fr)
ZA (1) ZA988638B (fr)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19954516A1 (de) 1999-11-12 2001-05-17 Boehringer Ingelheim Int Epinastin-haltige Lösungen
JP5592042B2 (ja) * 2000-04-14 2014-09-17 ジェイ−メド ファーマシューティカルズ，インコーポレーティッド 鼻炎治療のための単一投与抗ヒスタミン薬／鬱血除去薬製剤
SK2805U (sk) * 2000-10-05 2001-03-12 Unimed Pharma Spol Sro Očná instilácia s dekongescentným účinkom
US20020094345A1 (en) 2000-10-06 2002-07-18 Sara Abelaira Pharmaceutical compositions containing epinastine and pseudoephedrine
PE20020324A1 (es) * 2000-10-06 2002-06-18 Boehringer Ingelheim Int Nuevas composiciones farmaceuticas que contienen epinastina y pseudoefedrina
FR2833493B1 (fr) * 2001-12-18 2005-09-23 Ioltechnologie Production Forme galenique solide et soluble pour l'administration occulaire de principes actifs et procede de fabrication d'un insert ophtalmique solide et soluble
EP1327463A1 (fr) * 2002-01-04 2003-07-16 Oramon Arzneimittel GmbH Cel contenant Cetirizine et Loratadine à l'usage topique
GB2389530B (en) 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
WO2004000272A1 (fr) * 2002-06-20 2003-12-31 Novartis Consumer Health S.A. Compositions nasales contenant un glycosaminoglycane et un propylene glycol
CN103143022A (zh) 2002-07-30 2013-06-12 奥默罗斯公司 眼科冲洗液及方法
PL373433A1 (en) * 2002-08-30 2005-08-22 Altana Pharma Ag The use of the combination of ciclesonide and antihistamines for the treatment of allergic rhinitis
US7714011B2 (en) * 2002-09-13 2010-05-11 Zicam, Llc Compositions to reduce congestion and methods for application thereof to the nasal membrane
WO2004069157A2 (fr) * 2003-01-17 2004-08-19 Ophthalmic Research Associates, Inc. Utilisation combinee d'anti-histaminiques a action prolongee et a action breve contre les allergies oculaires
JP2010241834A (ja) * 2003-02-19 2010-10-28 Rohto Pharmaceut Co Ltd 医薬組成物
JP2007039473A (ja) * 2003-02-19 2007-02-15 Rohto Pharmaceut Co Ltd 医薬組成物
JP2005330245A (ja) * 2004-05-21 2005-12-02 Kowa Co 鼻炎用薬
DE102004049008A1 (de) * 2004-10-05 2006-04-06 Merck Patent Gmbh Neue Verwendung für α-Sympathomimetika mit 2-Imidazolinstruktur
US8758816B2 (en) 2004-11-24 2014-06-24 Meda Pharmaceuticals Inc. Compositions comprising azelastine and methods of use thereof
US20070020330A1 (en) * 2004-11-24 2007-01-25 Medpointe Healthcare Inc. Compositions comprising azelastine and methods of use thereof
DK2486942T3 (en) * 2004-11-24 2019-01-28 Meda Pharmaceuticals Inc COMPOSITIONS CONTAINING AZELASTINE AND PROCEDURES FOR USING IT
US7247623B2 (en) * 2005-08-19 2007-07-24 Inspire Pharmaceuticals, Inc. Method of treating dry eye disease with non-drying antihistamines
US20090136598A1 (en) * 2006-04-26 2009-05-28 Aciex, Inc. Compositions for the Treatment and Prevention of Eyelid Swelling
US8685439B2 (en) * 2006-04-26 2014-04-01 Aciex Therapeutics, Inc. Method for the treatment and prevention of eyelid swelling
US7378082B1 (en) 2007-11-05 2008-05-27 Inspire Pharmaceuticals, Inc. Method for treating allergic rhinitis without adverse effects
JP2008285474A (ja) * 2007-04-17 2008-11-27 Daiichi Sankyo Healthcare Co Ltd 抗アデノウイルス剤を含有する医薬組成物
ES2518418T3 (es) 2008-08-01 2014-11-05 Eye Therapies Llc Composiciones de vasoconstricción y métodos de uso
US20110257188A1 (en) * 2008-08-01 2011-10-20 Gerald Horn Compositions and methods for the treatment of nasal conditions
US20150119401A1 (en) * 2008-08-01 2015-04-30 Eye Therapies, Llc Compositions and Methods for the Treatment of Nasal Conditions
US20120156244A1 (en) * 2008-08-01 2012-06-21 Alpha Synergy Development Inc. Nasal Compositions and Uses Thereof
US8952011B2 (en) 2008-08-01 2015-02-10 Eye Therapies Llc Compositions and methods for the treatment of nasal conditions
US12246013B2 (en) 2008-08-01 2025-03-11 Eye Therapies Llc Vasoconstriction compositions and methods of use
CA2755679C (fr) * 2009-03-17 2017-09-12 Aciex Therapeutics, Inc. Formulations ophtalmiques de cetirizine et procedes d'utilisation
US8569273B2 (en) 2009-03-17 2013-10-29 Aciex Therapeutics, Inc. Ophthalmic formulations of cetirizine and methods of use
US20120225918A1 (en) * 2011-03-03 2012-09-06 Voom, Llc Compositions and Methods for Non-Surgical Treatment of Ptosis
JP5752578B2 (ja) * 2011-12-09 2015-07-22 ジェイ−メド ファーマシューティカルズ，インコーポレーティッド 鼻炎治療のための単一投与抗ヒスタミン薬／鬱血除去薬製剤
AU2013201465B2 (en) 2012-10-24 2016-03-03 Rayner Intraocular Lenses Limited Stable preservative-free mydriatic and anti-inflammatory solutions for injection
US11135155B2 (en) 2014-07-08 2021-10-05 Hikma Pharmaceuticals Usa Inc. Liquid naloxone spray
EP3212186A1 (fr) * 2014-10-31 2017-09-06 Avon Products, Inc. Compositions topiques et procédés d'utilisation de ces compositions
TWI705812B (zh) 2014-12-01 2020-10-01 奥默羅斯公司 用於抑制術後眼睛炎性病況的抗炎和散瞳前房溶液
DE102016125378A1 (de) * 2016-12-22 2018-06-28 Werner Schmidt Zusammensetzung zur Behandlung von Erkältungskrankheiten
TW201841620A (zh) * 2017-05-01 2018-12-01 日商參天製藥股份有限公司 點眼劑
RU2744097C2 (ru) * 2018-02-28 2021-03-02 Акционерное Общество "Вертекс" Комбинированное противоаллергическое лекарственное средство для назального применения

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3822349A (en) * 1969-06-02 1974-07-02 C Kosti Vasoconstrictor-antihistamine composition for the treatment of hypertrophied oral tissue
JPH07188002A (ja) * 1993-12-27 1995-07-25 Taisho Pharmaceut Co Ltd 鼻炎治療用組成物

Also Published As

Publication number Publication date
ES2171356B2 (es) 2004-05-01
BR9812361A (pt) 2000-09-19
NO20001459D0 (no) 2000-03-21
CA2304162A1 (fr) 1999-04-01
US20020037297A1 (en) 2002-03-28
JP2001517639A (ja) 2001-10-09
PL339541A1 (en) 2000-12-18
AU9540098A (en) 1999-04-12
DE19882573T1 (de) 2000-10-26
WO1999015203A1 (fr) 1999-04-01
EP0903151A1 (fr) 1999-03-24
NO20001459L (no) 2000-03-21
ES2171356A1 (es) 2002-09-01

Similar Documents

Publication Publication Date Title
PL339541A1 (en) Application of combinations containing non-calming antihistaminic agents and alpha-adrenergic drug in locally treating rhinitis/ophtalmitis as well as cold and cold symptoms and/or influenza
NO996483L (no) Imidasopyrimidiner og imidasopyridiner for behandling av neurologiske lidelser
NO20022680L (no) Farmasoytiske kombinasjoner og deres anvendelse ved behandling av gastrointestinale forstyrrelser
PL344535A1 (en) Use of organophosphoric compounds for the therapeutic and preventative treatment of infections
NO20001754D0 (no) Prostaglandinagonister og anvendelse derav for behandling av benforstyrrelser
SI1231920T1 (sl) Uporaba epinastina za zdravljenje alergijskega renitisa/konjuktivitisa
IL128379A0 (en) Treatment of the common cold or allergic rhinitis
IL138732A0 (en) The use of polyamines in the treatment of dermatological symptoms
IL145301A0 (en) 1-arenesulfonyl-2-aryl-pyrrolidine and piperidine derivatives for the treatment of cns disorders
AU2002346644A1 (en) Use of fpt inhibitors and at least two antineoplastic agents in the treatment of cancer
NO20021784D0 (no) Anvendelse av dipyridamol eller mopidamol for fremstilling av et medikament for behandling og forebygging av fibrin-avhengigmikrosirkulasjonsforstyrrelser
ZA200208228B (en) Use of il-18 inhibitors for the treatment and/or prevention of athesclerosis
HU9802971D0 (en) The use of mmp inhibitors for the treatments of ocular angiogenesis
PL376894A1 (pl) Pochodne 4-(fenylopiperazynylometylo) benzamidu i ich zastosowanie do leczenia bólu lub zaburzeń żołądkowo-jelitowych
AU2003286285A1 (en) Use of fgf-18 in the diagnosis and treatment of memory disorders
HUP0303306A3 (en) Use of il-18 inhibitors for the treatment and/or prevention of heart disease
PL376895A1 (pl) Pochodne 4-(fenylopiperazynylometylo) benzamidu i ich zastosowanie do leczenia bólu lub zaburzeń żołądkowo-jelitowych
NO20013651D0 (no) Anvendelse av fosfororganiske forbindelser for profylaktisk og terapeutisk behandling av infeksjoner
HUP0202339A3 (en) Use of cortisol antagonists in the treatment of heat failure
NO20013408D0 (no) Anvendelse av 2-substituerte 1,2-benzisotiazol-derivater og 3- substituerte tetrahydropyridopyrimidinon-derivater for profylakseog terapi av cerebral ischemi
AU8626398A (en) Inhibitors of the phosphodiesterase-4 for the treatment of allergic rhinitis
ID28817A (id) Penggunaan turunan-turunan tetrahidropiridin (atau4-hidropiperidin)-butilazol dalam pembuatan obat untuk perawatan nyeri
SI1117403T1 (en) Mglur5 antagonists for the treatment of pain and anxiety
HUP9903881A3 (en) Benzenesulfonamide derivatives usable for the prevention and/or treatment of thrombosis, asthma or allergic and use thereof
IT1304705B1 (it) Attrezzo per la prevenzione e cura della scoliosi